Related references
Note: Only part of the references are listed.Cardioverter-defibrillator does not improve short-term survival among patients with non-ischemic cardiomyopathy and reduced left ventricular ejection fraction
Clemens Jilek et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Medical treatment of octogenarians with chronic heart failure: data from CHECK-HF
Gerard C. M. Linssen et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction
Jozine M. ter Maaten et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: As-treated and per-protocol analyses
Jeffrey E. Olgin et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2020)
Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials
Xavier Rossello et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
Rasmus Rorth et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction
Pieter Martens et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction
Chan Soon Park et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
One-year follow-up of the prospective registry of patients using the wearable defibrillator (WEARIT-II Registry)
Valentina Kutyifa et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2018)
Wearable Cardioverter-Defibrillator after Myocardial Infarction
Jeffrey E. Olgin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Usefulness of the WCD in patients with suspected tachymyopathy
Julia W. Erath et al.
CLINICAL RESEARCH IN CARDIOLOGY (2018)
The wearable cardioverter-defibrillator: current technology and evolving indications
Sven Reek et al.
EUROPACE (2017)
The impact of co-morbidity burden on appropriate implantable cardioverter defibrillator therapy and all-cause mortality: insight from Danish nationwide clinical registers
Anne Christine Ruwald et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Kenneth C. Bilchick et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study
David Duncker et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: Insights from the PROLONG study
David Duncker et al.
CLINICAL CARDIOLOGY (2017)
Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis
David Duncker et al.
CLINICAL RESEARCH IN CARDIOLOGY (2017)
Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death
Nadine K. Waessnig et al.
CIRCULATION (2016)
Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory From the American Heart Association
Jonathan P. Piccini et al.
CIRCULATION (2016)
Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival Results From the Valsartan Heart Failure Trial
Viorel G. Florea et al.
Circulation-Heart Failure (2016)
Predicting Persistent Left Ventricular Dysfunction Following Myocardial Infarction The PREDICTS Study
Gabriel C. Brooks et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure
Lars Kober et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction A Meta-Analysis
Marcello Disertori et al.
JACC-CARDIOVASCULAR IMAGING (2016)
Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction
Andreas P. Kalogeropoulos et al.
JAMA CARDIOLOGY (2016)
Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac Patients Data From the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry)
Valentina Kutyifa et al.
CIRCULATION (2015)
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Silvia G. Priori et al.
EUROPACE (2015)
Evolution of Left Ventricular Ejection Fraction After Acute Myocardial Infarction Implications for Implantable Cardioverter-Defibrillator Eligibility
Johanna Sjoblom et al.
CIRCULATION (2014)
Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator
David Duncker et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Early Risk of Mortality After Coronary Artery Revascularization in Patients With Left Ventricular Dysfunction and Potential Role of the Wearable Cardioverter Defibrillator
Edwin T. Zishiri et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2013)
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator
Helmut U. Klein et al.
EUROPEAN HEART JOURNAL (2013)
Wearable Cardioverter-Defibrillator Use in Patients Perceived to Be at High Risk Early Post-Myocardial Infarction
Andrew E. Epstein et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
How Can Optimization of Medical Treatment Avoid Unnecessary Implantable Cardioverter-Defibrillator Implantations in Patients With Idiopathic Dilated Cardiomyopathy Presenting With SCD-HeFT Criteria?
Massimo Zecchin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Aggregate National Experience With the Wearable Cardioverter-Defibrillator Event Rates, Compliance, and Survival
Mina K. Chung et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Defibrillator Implantation Early after Myocardial Infarction
Gerhard Steinbeck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
SH Hohnloser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: Results of WEARIT/BIROAD
AM Feldman et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2004)
Share Paper
